Streetbeat News

Stock Prices

DFLI

Dragonfly Energy Holdings reported a year-over-year decrease in Q3 financial results and provided Q4 revenue guidance below estimates, leading to a downgrade by Roth MKM from Buy to Neutral. This has resulted in the company's shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:13 pm

TSN

Tyson Foods, Inc. (NYSE:TSN) reported Q4 earnings of 37 cents per share, surpassing estimates of 29 cents per share. However, sales of $13.35 billion fell short of the expected $13.73 billion. The company forecasts FY24 adjusted operating income between $1 billion and $1.5 billion. Following the earnings report, Tyson's stock rose 3.8% to $47.33. Analysts at BMO Capital, JP Morgan, and Stephens & Co. updated their price targets and ratings for Tyson Foods.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 7:11 pm

ABNB

ADBE

COIN

ZM

Adobe Inc.'s proposed $20 billion acquisition of Figma Inc. is expected to face an antitrust warning from the European Commission. The Commission is preparing a statement of objections, highlighting concerns about potential anti-competitive effects of the deal. The EU initiated an in-depth investigation into the takeover in August over concerns of reduced competition in the market for interactive product design tools. Figma collaborates with companies like Zoom Video Communications, Airbnb, and Coinbase Global. The Commission's decision on the deal is expected by February 5.

Portfolio Pulse from Nabaparna Bhattacharya

November 14, 2023 | 7:10 pm

SPCB

SuperCom's stock is trading higher following the report of improved Q3 adjusted EPS and revenue results that surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:08 pm

VTGN

Stifel initiated coverage on Vistagen Therapeutics Inc (VTGN) with a Buy rating and a $12 price target, citing the potential of its lead asset, fasedienol, for social anxiety disorder. Despite a mixed outcome in previous studies, success in upcoming trials could support a marketing application. VTGN's valuation is seen as undervalued for a phase 3 CNS asset, with a current market cap around $60 million. VTGN shares rose 16.90% to $3.19.

Portfolio Pulse from Vandana Singh

November 14, 2023 | 7:08 pm

BTAI

BioXcel Therapeutics' stock price has declined following the announcement of their Q3 financial results, which were below market expectations.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:07 pm

BCDA

LICY

SKIN

XAIR

Beyond Air, Inc. (XAIR) shares dropped by 37.3% to $1.2701 due to weaker than expected quarterly results, with a loss of 51 cents per share and sales of $239,000 against expectations of $480,000. Other stocks experienced significant movements in Tuesday's mid-day session, with notable gainers including BioCardia, Inc. (BCDA), reAlpha Tech Corp. (AIRE), and Theseus Pharmaceuticals, Inc. (THRX), among others. Losers included Li-Cycle Holdings Corp. (LICY) and The Beauty Health Company (SKIN), which both saw sharp declines after reporting disappointing financial results.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 7:05 pm

NVO

Belgium has temporarily banned the use of Novo Nordisk's Ozempic for weight loss due to a medication shortage. Ozempic, primarily for Type 2 diabetes, has been used off-label for weight loss, increasing demand. The ban aims to preserve supplies for diabetic patients, with restricted availability expected until June 2024. Novo Nordisk is investing to increase supply, with a recent $6 billion investment to expand manufacturing in Denmark. NVO shares dropped 1.55% following the news.

Portfolio Pulse from Vandana Singh

November 14, 2023 | 7:05 pm

HYZN

Hyzon Motors Inc (NASDAQ:HYZN) shares surged after reporting Q3 FY23 results. Despite a wider net loss of $(41.1) million and a loss per share of $(0.18), exceeding consensus estimates, the company showed progress by delivering its first revenue-generating FCEV in North America and deploying 14 FCEVs under commercial agreements. Operational efficiencies led to the lowest cash burn in eight quarters. The company also resolved an SEC investigation with a $25 million penalty and appointed a new CFO, Stephen Weiland. HYZN's stock rose 35.75% to $1.07.

Portfolio Pulse from Lekha Gupta

November 14, 2023 | 7:05 pm

RNLX

Renalytix reported a year-over-year decrease in Q1 sales results, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:04 pm